Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Anti-PD-1 monoclonal antibody suppresses hepatitis B virus in patients with hepatocellular carcinoma.

Chinese medical journal·2026
Same author

Activatable Immunotheranostic Nanovesicles for Coordinated Phagocytic Reprogramming and Real-Time Immune Monitoring.

Journal of the American Chemical Society·2026
Same author

Fat-muscle balance and incident diabetes: evidence from Chinese and UK cohorts.

Diabetes research and clinical practice·2026
Same author

CILP2 exacerbates diabetes-induced muscle atrophy by over-activating skeletal muscle autophagy and inflammation via the P38 MAPK pathway.

International immunopharmacology·2026
Same author

Short-Term Combined Treatment With Tirzepatide and Metformin for Overweight/Obese Chinese Women With Polycystic Ovary Syndrome: A Prospective, Open-Label, Randomised Controlled Trial.

Diabetes, obesity & metabolism·2026
Same author

In-Situ Self-Assembling Multifunctional Peptide-Hydrogel Enables Efficient Bladder Cancer Therapy via Sustained Release of Bacillus Calmette-Guérin and Enhanced Immune Response.

ACS applied materials & interfaces·2026
Same journal

Three in One: Luminol, Hemin, and GOx-Encapsulated UiO-66 for Rapid and Sensitive Chemiluminescence Detection of Glucose.

Luminescence : the journal of biological and chemical luminescence·2026
Same journal

Surface Passivation and Luminescence Mechanisms in InP Quantum Dots Toward High-Efficiency and Stable QLED Emission.

Luminescence : the journal of biological and chemical luminescence·2026
Same journal

Efficient Moderate-to-High Temperature Optical Thermometry Enabled by Valley-to-Peak Ratio and Lattice Negative Thermal Expansion.

Luminescence : the journal of biological and chemical luminescence·2026
Same journal

Synthesis and NIR Emission in Rankinite Ca<sub>3</sub>Si<sub>2</sub>O<sub>7</sub>:Nd<sup>3+</sup> Phosphor for Optical Applications.

Luminescence : the journal of biological and chemical luminescence·2026
Same journal

Unfolding of Eco-Innovative Multifunctional Switch-Off Fluorescent Sensor for Omeprazole Sensing in Formulations and Environmental Samples.

Luminescence : the journal of biological and chemical luminescence·2026
Same journal

Influence of La<sub>2</sub>O<sub>3</sub> on the Structure, Thermal, and Luminescence Properties of Er<sup>3+</sup>-Doped TeO<sub>2</sub>-Ga<sub>2</sub>O<sub>3</sub>-BaF<sub>2</sub> Glass.

Luminescence : the journal of biological and chemical luminescence·2026
See all related articles

Related Experiment Video

Updated: Jul 4, 2025

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
09:12

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

913

Hypoxia-responsive AIEgens for precise disease theranostics.

Dongfang Liu1,2, Mengyun Liang3, Aohua Fan1,2

  • 1Key Laboratory of Bionic Engineering, Ministry of Education, Jilin University, Changchun, China.

Luminescence : the Journal of Biological and Chemical Luminescence
|January 29, 2024
PubMed
Summary
This summary is machine-generated.

Hypoxia-responsive aggregation-induced emission luminogens (AIEgens) offer precise disease diagnosis and treatment. These probes detect low-oxygen conditions, enhancing precision medicine for conditions like cancer and ischemia.

Keywords:
aggregation-induced emissionhypoxianear-infraredphotodynamic therapytheranostics

More Related Videos

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
07:07

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Published on: February 14, 2025

2.6K
Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
09:17

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

18.2K

Related Experiment Videos

Last Updated: Jul 4, 2025

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
09:12

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

913
Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
07:07

Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance

Published on: February 14, 2025

2.6K
Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions
09:17

Co-immunoprecipitation Assay Using Endogenous Nuclear Proteins from Cells Cultured Under Hypoxic Conditions

Published on: August 2, 2018

18.2K

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Medical Imaging

Background:

  • Hypoxia, a low-oxygen state, is a key factor in diseases like cancer and ischemia.
  • Aggregation-induced emission luminogens (AIEgens) are advanced materials with unique optical properties.
  • Biomarker-activatable probes are crucial for precision medicine and theranostics.

Purpose of the Study:

  • To review recent advancements in hypoxia-responsive AIEgens for biomedical applications.
  • To highlight the role of AIEgens in sensing and responding to hypoxic microenvironments.
  • To discuss the potential of these probes in disease diagnosis and therapy.

Main Methods:

  • Review of literature on hypoxia-responsive AIEgens and their structures (e.g., azobenzene, nitrobenzene, N-oxide).
  • Analysis of how AIEgen structures respond to hypoxic reduction, altering spectral and fluorescence properties.
  • Examination of bioapplications in imaging and therapy for tumors and ischemic diseases.

Main Results:

  • Hypoxia-responsive AIEgens exhibit significant spectral and fluorescence changes due to reduction-triggered structural alterations.
  • These probes demonstrate efficacy in imaging and therapeutic applications for cancer and ischemia.
  • Specific structural motifs like azobenzene, nitrobenzene, and N-oxide are effective in hypoxia sensing.

Conclusions:

  • Hypoxia-responsive AIEgens represent a significant advancement in theranostics and precision medicine.
  • These probes offer enhanced precision for diagnosing and treating hypoxia-related diseases.
  • Further development holds promise for improved patient outcomes in oncology and ischemia treatment.